Because Sep15 deficiency in mouse colon cancer cells as well as in Sep15 knockout mice in vivo demonstrated a highly increased expression of GBP-1 compared to controls [14,17], mRNA expression of GBP-1 was also evaluated in human colon cancer cells. This evidence concerns the gene SELENOF and colonic neoplasm.